ARDANT PHARMACEUTICALS LTD.

09126357
Active Henwood

Wholesale of pharmaceutical goods

16 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
A

ARDANT PHARMACEUTICALS LTD.

09126357

Wholesale of pharmaceutical goods

Founded 11 Jul 2014 Active Henwood, England 16 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods

Previous Company Names

PHARMABROKER EU LIMITED 11 Jul 2014 — 9 Mar 2018
Accounts Submitted 27 Jan 2025 Next due 31 Dec 2025 7 months overdue
Confirmation Submitted 15 Jan 2025 Next due 29 Jan 2026 6 months overdue
Net assets £-1M £779K 2023 year on year
Total assets £1M £676K 2023 year on year
Total Liabilities £3M £1M 2023 year on year
Charges 5
2 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

Unit 1 Vanguard Industrial Estate Henwood Ashford TN24 8DH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ARDANT PHARMACEUTICALS LTD. (09126357), an active life sciences and medical technology company based in Henwood, England. Incorporated 11 Jul 2014. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2024
Type total-exemption-full
Next accounts 31 Mar 2025
Due by 31 Dec 2025 7 months overdue

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

£22.61k

Net Assets

-£1.25M

Decreased by £779.15k (-165%)

Total Liabilities

£2.72M

Increased by £1.46M (+115%)

Turnover

N/A

Employees

16

Increased by 11 (+220%)

Debt Ratio

185%

Increased by 26 (+16%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

James Anthony Aylott
100.0%
1,000
Pharmapro Healthcare Ltd
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 7 Ceased

James Anthony Aylott

British

Active
Notified 11 Oct 2024
Residence United Kingdom
DOB April 1971
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

James Anthony Aylott

Ceased 9 Sept 2023

Ceased

Pharmapro Healthcare Ltd

Ceased 17 Sept 2023

Ceased

Abri Coetzee

Ceased 17 Sept 2023

Ceased

James Anthony Aylott

Ceased 17 Sept 2023

Ceased

Pharmapro Healthcare Ltd

Ceased 11 Oct 2024

Ceased

Abri Coetzee

Ceased 12 Dec 2024

Ceased

Sandeep Askok Patel

Ceased 12 Mar 2018

Ceased

Group Structure

Group Structure

ARDANT PHARMACEUTICALS LTD. Current Company

Charges

Charges

2 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 May 2026InsolvencyLiquidation Disclaimer Notice
14 Feb 2025MortgageMortgage Satisfy Charge Full
12 Feb 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
27 Jan 2025AccountsAnnual accounts made up to 31 Mar 2024
16 Jan 2025Persons With Significant ControlChange to Mr James Anthony Aylott as a person with significant control on 31 Dec 2024
11 May 2026 Insolvency

Liquidation Disclaimer Notice

14 Feb 2025 Mortgage

Mortgage Satisfy Charge Full

12 Feb 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

27 Jan 2025 Accounts

Annual accounts made up to 31 Mar 2024

16 Jan 2025 Persons With Significant Control

Change to Mr James Anthony Aylott as a person with significant control on 31 Dec 2024

Recent Activity

Latest Activity

Liquidation Disclaimer Notice

1 months ago on 11 May 2026

Mortgage Satisfy Charge Full

1 years ago on 14 Feb 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

1 years ago on 12 Feb 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 27 Jan 2025

Change to Mr James Anthony Aylott as a person with significant control on 31 Dec 2024

1 years ago on 16 Jan 2025